To create a predictive model for the identification of gestational diabetes risk. STUDY DESIGN: A predictive model to identify risk of developing gestational diabetes was created using a supervised machine learning algorithm, specifically, a Gradient Boosting Decision Tree algorithm, as well as data from 62,110 users of the mobile app Ovia Pregnancy. Data collected from users prior to the 24th week of pregnancy were used in the model. This allowed the model to predict risk of developing gestational diabetes beginning at week 24. RESULTS: Of the total sample used to train the model, 49% had gestational diabetes based on patient report of a diagnosis made by their healthcare provider. The model used 4,070 different features to model gestational diabetes risk. Self-report data, as well as in-app calculations based on reported data, were used to create the model. The features most influential to the model were 'daily data' such as, health symptoms (e.g., fatigue, blood pressure); characteristics of the current pregnancy including whether it was a single or multiple gestation; personal health history information; and personal demographic information including age and BMI (height and weight). The model's positive predictive value was 0.75, with 0.75 sensitivity. CONCLUSION: This model based on patient-reported data could predict risk for developing gestational diabetes, a serious obstetric complication, with accuracy levels sufficient to guide clinical screening by healthcare providers and health plans. Ochsner Health System, New Orleans, LA OBJECTIVE: Early screening for GDM in obese women is recommended but a particular method of screening has not been specified. Hemoglobin A1c (HbA1c), which is convenient and low-cost, is frequently used to screen for diabetes in non-pregnant individuals. We aimed to assess the clinical utility of using HbA1c to screen for GDM at 14-20 weeks of pregnancy. STUDY DESIGN: Secondary analysis of RCT comparing early GDM screening (14-20 weeks) to routine screening (24-28 weeks) in obese women (BMI 30kg/m 2 ) with singleton, non-anomalous pregnancies. Exclusion criteria were known diabetes, major medical illness (cardiac, hemoglobinopathy, prednisone use), bariatric surgery, and prior cesarean. Screening was performed with a 50-g, 1-hour glucose challenge test, followed by a 100-g, 3-hour glucose tolerance test if the initial result was 135 mg/dL. In addition, HbA1c was measured on all patients, and GDM was diagnosed if this was 6.5. In women who had a normal screen at 14-20 weeks, repeat screening was performed at 24-28 weeks. For the current analysis, women who had a normal HbA1c in early pregnancy and screening for GDM at 24-28
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